Race/ethnicity and nonadherence to prescription medications among seniors: Results of a national study

Journal of General Internal Medicine

Volumn 22, Issue 11, 2007, Pages 1572-1578

  Gellad, Walid F ^a   Haas, Jennifer S ^a   Safran, Dana Gelb ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug therapy economics; Health disparities; Medication adherence

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CAUCASIAN; CHRONIC DISEASE; DRUG COST; EDUCATION; ETHNICITY; FEMALE; HISPANIC; HUMAN; INCOME; MALE; NEGRO; PATIENT COMPLIANCE; PRESCRIPTION; RACE DIFFERENCE; SEX DIFFERENCE;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DRUG THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH CARE SURVEYS; HISPANIC AMERICANS; HUMANS; LOGISTIC MODELS; MALE; MEDICARE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; POVERTY; UNITED STATES;

EID: 35248814765     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-007-0385-z     Document Type: Article

References (34)

1. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood) 2005; Suppl Web Exclusives: W5-152-W155-166.
2. Soumerai SB, Pierre-Jacques M, Zhang F, et al. Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries: a national survey 1 year before the Medicare drug benefit. Arch Intern Med. 2006;166(17):1829-35.
3. Tseng CW, Brook RH, Keeler E, Steers WN, Mangione CM. Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA. 2004;292(8):952-60.
4. Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11(11):730-40.
5. Gibson TB, Mark TL, McGuigan KA, Axelsen K, Wang S. The effects of prescription drug copayments on statin adherence. Am J Manag Care. 2006;12(9):509-17.
6. Goldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291(19):2344-50.
7. Adams AS, Soumerai SB, Ross-Degnan D. The case for a Medicare drug coverage benefit: a critical review of the empirical evidence. Annu Rev Public Health. 2001;22:49-61.
8. Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27(2):384-91.
9. Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004;42(2):102-9.
10. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285(4):421-9.
11. Heisler M, Langa KM, Eby EL, Fendrick AM, Kabeto MU, Piette JD. The health effects of restricting prescription medication use because of cost. Med Care. 2004;42(7):626-34.
12. Mojtabai R. Medication Costs, Adherence, and Health Outcomes Among Medicare Beneficiaries. Health Aff (Millwood). 2003;22(4):220-9.
13. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836-41.
14. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298(1):61-9.
15. Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354(22):2349-59.
16. Smedley BD, Stith AY, Nelson AR, eds. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, D.C.: National Academy Press; 2003.
17. Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med. 2005;353(7):692-700.
18. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25(6):1015-21.
19. Wilson IB, Rogers WH, Chang H, Safran DG. Cost-related skipping of medications and other treatments among Medicare beneficiaries between 1998 and 2000. Results of a national study. J Gen Intern Med. 2005;20(8):715-20.
20. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94(10):1782-7.
21. Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001;16(12):793-9.
22. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health. 1996;86(12):1805-8.
23. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.
24. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: how well are states closing the gap? Health Aff (Millwood). 2002;Suppl Web Exclusives:W253-68.
25. Buck SF. A method of estimation of missing values in multivariate data suitable for use with an electronic computer. J R Stat Soc. 1960;B22:302-6.
26. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164(16):1749-55.
27. Wilson IB, Schoen C, Neuman P, et al. Physician-patient communication about prescription medication nonadherence: a 50-state study of America's seniors. J Gen Intern Med. 2007;22(1):6-12.
28. Prescription Drug Coverage Among Medicare Beneficiaries. Menlo Park, CA: The Henry J. Kaiser Family Foundation; June 2006.
29. Gellad WF, Huskamp HA, Phillips KA, Haas JS. How the new Medicare drug benefit could affect vulnerable populations. Health Aff (Millwood). 2006;25(1):248-55.
30. Heiss F, McFadden D, Winter J. Who failed to enroll in Medicare part d, and why? Early results. Health Aff (Millwood). 2006;25(5):w344-54.
31. Rector TS, Venus PJ. Do drug benefits help medicare beneficiaries afford prescribed drugs. Health Aff. 2004;23(4):213-22.
32. Weingart SN, Gandhi TK, Seger AC, et al. Patient-reported medication symptoms in primary care. Arch Intern Med. 2005;165(2):234-40.
33. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556-64.
34. Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42(7):649-52.